Rationality of routine clinical use of olokizumab in COVID-19
oleh: V. M. Tsvetov, A. V. Matveev, D. A. Sychev
| Format: | Article |
|---|---|
| Diterbitkan: | Izdatelstvo OKI 2020-10-01 |
Deskripsi
Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials.